Skip to Main Content (Press Enter)
×
Home
Corsi
Insegnamenti
Professioni
Persone
Pubblicazioni
Strutture
Terza Missione
Competenze
IT
EN
☰
Competenze e Professionalità
|
UNIFIND
-
Competenze e Professionalità
unime.it
IT
EN
×
Home
Corsi
Insegnamenti
Professioni
Persone
Pubblicazioni
Strutture
Terza Missione
Competenze
☰
Pubblicazioni
BLOOD
Rivista
Codice:
E023052
ISSN:
0006-4971
Dati Generali
Dati Generali
Pubblicazioni (39)
Pulisci
Ordina Pubblicazioni:
ascendente
decrescente
Abnormal intracellular kinetics of cell-cycle-dependent proteins in lymphocytes from patients infected with human immunodeficiency virus: A novel biologic link between immune activation, accelerated T-cell turnover, and high levels of apoptosis
Articolo
BCR-ABL nuclear entrapment kills human CML cells: Ex vivo study on 35 patients with the combination of imatinib mesylate and leptomycin B
Articolo
CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells.
Articolo
Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma
Articolo
DASATINIB INDUCES A RESPONSE IN CHRONIC LYMPHOCYTIC LEUKEMIA
Articolo
Different STAT-3 and STAT-5 phosphorylation discriminates among Ph-negative chronic myeloproliferative diseases and is independent of the V617F JAK-2 mutation
Articolo
Distinct signals control the hematopoiesis of lymphoid-related dendritic cells
Articolo
Effect of human plasma-derived protein C and murine recombinant protein C on severe neonatal sepsis in mice.
Articolo
Effects and outcome of a policy of intermittent imatinib treatment in elderly patients with chronic myeloid leukemia
Articolo
Efficacy and Safety of Ixazomib-Dexamethasone, Ixazomib-Cyclophosphamide-Dexamethasone, Ixazomib-Thalidomide-Dexamethasone and Ixazomib-Bendamustine-Dexamethasone for Elderly Newly Diagnosed Multiple Myeloma (NDMM) Patients: Analysis of the Phase II Randomized Unito-EMN10 Study
Abstract
Efficacy and safety of once-weekly bortezomib in multiple myeloma patients
Articolo
Erratum: Effects and outcome of a policy of intermittent imatinib treatment in elderly patients with chronic myeloid leukemia (Blood (2013) 121:26 (5138-5144))
Articolo
Expression of p15(ink4b) gene during megakaryocytic differentiation of normal and myelodysplastic hematopoietic progenitors
Articolo
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis
Articolo
Generation of immunogenic dendritic cells that are gene-modified to present the ERBB2 antigen.
Articolo
Human NK cells of mice with reconstituted human immune system components require pre-activation to acquire functional competence.
Articolo
Human dendritic cell subtypes differ in ability to stimulate resting NK cells.
Articolo
Increased GILZ expression in transgenic mice up-regulates Th-2 lymphokines
Articolo
Increased tumor burden in patients with chronic myeloid leukemia after 36 months of imatinib discontinuation
Articolo
Influenza vaccination in asplenia: improving quality of care in time of Coronavirus.
Articolo
LONG-TERM RESULTS FROM MOPPEBVCAD CHEMOTHERAPY WITH OPTIONAL LIMITED RADIOTHERAPY IN ADVANCED HODGKIN'S DISEASE
Articolo
Long-term results from MOPPEBVCAD chemotherapy with optional limited radiotherapy in advanced Hodgkin's disease
Articolo
Lymphoid progenitor cells generate powerful antigen-presenting dendritic cells along a monocyte-independent pathway.
Articolo
Mature myeloid dendritic cell subsets have distinct roles for activation and viability of circulating human natural killer cells
Articolo
Multi-omics analysis in IgM monoclonal gammopathies reveals epigenetic influence on oncogenesis via DNA methylation
Articolo
Nilotinib for the frontline treatment of Ph+ chronic myeloid leukemia
Articolo
Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response: The NEXT-in-CML study
Articolo
Prospective changes of pancreatic iron in thalassemia major.
Abstract
RGDS peptide induces caspase 8 and caspase 9 activation in human endothelial cells
Articolo
Results of high dose of imatinib mesylate in intermediate Sokal risk chronic myeloid leukemia patients in early chronic phase trial of the GIMEMA Working Party
Articolo
Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: Pooled results from 3 phase 2 trials
Articolo
SQUID biosusceptometry in hematological diseases
Articolo
Safety and efficacy of bortezomib-melphalan-prednisone-thalidomide followed by bortezomib-thalidomide maintenance (VMPT-VT) versus bortezomib-melphalan-prednisone (VMP) in untreated multiple myeloma patients with renal impairment.
Articolo
Serum concentration of cardiac Troponin T in patients with hypereosinophilic syndrome treated with imatinib is predictive of adverse outcomes
Articolo
Successful healing of hydroxyurea-related leg ulcers with topical granulocyte-macrophage colony-stimulating factor
Articolo
The PRV-1 gene expression in essential thrombocythemia
Articolo
The revised WHO diagnostic criteria for Ph-negative myeloproliferative diseases are not appropriate for the diagnostic screening of childhood polycythemia vera and essential thrombocythemia
Articolo
Triplet vs doublet lenalidomide-containing regimens for the treatment of elderly patients with newly diagnosed multiple myeloma
Articolo
Type II interleukin-1 receptor is not expressed in cultured endothelial cells and is not involved in endothelial cell activation.
Articolo
No Results Found
«
‹
{pageNumber}
›
»
{startItem} - {endItem} di {itemsNumber}
5 per pagina
10 per pagina
30 per pagina
vedi tutti
